So much financial shenanigans involved one can understand why a CFO would lack "technical expertise" to keep things on the up and up.

Does he have the "technical expertise" to do that?

Same people that let Nader Pourhassan run wild are still there collecting compensation, Scott Kelly and Nitya Ray. What have they achieved so far other than stuffing their pockets?

Cytodyn is paying its executives in shares instead of cash because it is broke. In other words, it is using shareholder equity to pay executives, thereby diluting its shareholders in the process. Scott Kelly and Nithya Ray, two executives that did nothing to reign in Nader Pourhassan while he was employed by the company, are receiving shares and are still employed by the company. What have they achieved?

I thought Nitya Ray said he's only there because of Nader and he'd quit if Nader's not there? Looks like he's addicted to the compensation.

Yep, its always about dangling a carrot for future success. We've seen Nadir run that play over and over here "golden quarter', "Mexico EUA", "HIV BLA", "Tripple digits" and now Scotty does the same "can't say anything because of NDAs". One would've been well served by watching what they do than what they say, and in the case of Nadir and Mike M, sell most of their shares into their bs hype.

The twice convicted felon Nadir Pourhassan was very generous with his version of the truth, basically said whatever it took to earn that $10M per year and sold his stock when the share price was roughly $3 when he promised "triple digit" future share price. He left the company a very wealthy man while shareholders who bought in believing his hype were devastated.

The $1M grant was to Sacha and his lab. Does not help Cytoydn's financial predicament one bit.

New CYDY pump in the works on all the forums. Sacha got a grant to do research involving the 24 year old drug and monkeys. When all else fails, pump the monkey research news! Does his grant bring CytoDyn any revenues? Can they pay back Samsung $35M?

The desperate hour has set in. The infamous Spokane Mike himself is commenting in the comments section of the new Seeking Alpha article with baseless speculation. Again, he does not disclose his current or former financial relationship with the company. Brazen.

Rubbish Spokane Mike paid pumper fluff. Company will be bankrupt by the end of this year.

Read the SEC filings to get a general idea. CYDY executives were served subpoenas, the company's promotional activities are being investigated, plus more. Its all in the SEC filings.

Whichever paid promoter spread the fraudulent news that Citibank had given a buy rating to CYDY (absurd to even think) should be very worried. That is outright stock fraud and manipulation and the SEC and DOJ probably added that to their long list of investigative items.

We all know there won't be any publicity whatsoever at the June 25 conference. The guy has multiple other posters up at the conference and I doubt he will be spending 1 second in front of the cytodyn one. He probably will take a postdoc with him to stand in front of the cytodyne one. If the NASH results were any good, we would have had PR from the company, yet they would rather let the embarrassing news of Pestell taking them to the cleaners sit as their top PR. Think about that.

Enron Linda made Nadir look like an amateur. I have never seen so much self-dealing by one company executive than in Enron Linda. Looks like she still has money to pay promoters to attack journalists and pump the stock.

If by a miracle they could ever get a BLA approved, the market will be tiny because no one will want to get weekly injections when alternatives exist which are twice a year injections. They blew it on HIV and could have gotten approval years ago if they had hired a competent CEO instead of a clueless felon hell bent on enriching himself and his cronies on the BOD. Remember that Bain Capital walked away from a potential investment because the CEO was a felon.

I know Nader is gone, but why does Scott or Chris stay silent? Why does the CEO stay silent, wait, my bad. Forgot they have no CEO. Maybe the former wine salesman Antonio can talk about CCR5 drugs?

The fact that execs are getting paid in stock proves there is no cash left in the treasury. Fully expect bankruptcy proceedings at any time. There will be no magical partnerships and there is no more data to spin as mTNBC and NASH were the last data to spin and both flopped.

In prior times Scotty or Naddir would have released a PR spinning the data saying how "wonderful" it was or some nonsensical wild percentage improvement. After two FDA letters they stay silent and let the naive retail or perhaps paid promotors do the talking.

Cliff Notes: if p>0.05, the trial failed. It means there was a greater than 5% chance the results were by random chance, and thus not statistically significant. If I need to be telling this to investors, they probably should not be investing in biotech.

Read the pinned abstract. From the abstract:

Mean percent change from baseline PDFF was significantly reduced in the 350 mg group vs placebo (-5.94% vs +9.85%, p = 0.008) but not in the 700 mg group (+3.75% vs +9.85%, p = 0.135). Mean change cT1 was significantly reduced in the 350 mg group vs placebo (-24.38 ms vs +27.64 ms, p = 0.021) but not in the 700 mg group (-2.73 ms vs +27.64 ms, p = 0.059).

Very bold of them to be doing this again after the 2 prior letters from the FDA.

Here are facts posted on every single CYDY page on its website:

IMPORTANT CORRECTION OF INVESTIGATIONAL DRUG INFORMATION

On February 11, 2022, CytoDyn, Inc. received a Warning Letter from the U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion in which FDA asserted that statements made in a video created a misleading impression regarding the safety and efficacy of leronlimab. Leronlimab is an investigational drug that has not been approved (or authorized) by the U.S. FDA for the treatment of COVID-19 or for any indication. For more information, click here to access a Dear Healthcare Provider (DHCP) Letter: View Here.

700mg double blind NASH results flopped as expected, and open label 350mg results were a cherry picked "success", as per cydy custom. Still no money to run any trials.

Looks likely. Look at Mahboob as an example, in and out getting paid well and hasn't opened his mouth about what he saw, most likely due to NDA. They all realize its junk science. HIV will never be approved with that 20 page RTF letter, hanging over it, not a simple "syringe issue" as told by the 2x felon / liar / thief/self-enricher. Is the data even solid, what with Amarex being accused by longs of doing shoddy work? A new CRO is going to come in and pick up the pieces and go through Amarex's work?

Anyone listen to the presentation at ASCO while eating at the food court?

Cytoydn just puts this statement top and center on every page on its website for no reason, right? Right?

IMPORTANT CORRECTION OF INVESTIGATIONAL DRUG INFORMATION

On February 11, 2022, CytoDyn, Inc. received a Warning Letter from the U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion in which FDA asserted that statements made in a video created a misleading impression regarding the safety and efficacy of leronlimab. Leronlimab is an investigational drug that has not been approved (or authorized) by the U.S. FDA for the treatment of COVID-19 or for any indication. For more information, click here to access a Dear Healthcare Provider (DHCP) Letter: View Here.

Who exactly are the private investors that Paulson is getting to bite even now? If they are anything like past investors most likely unsophisticated small business owners - pizzerias, laundromats, etc. Insiders - Scott Kelly et al, are certainly not buying shares using their own money. Nader Pourhassan always gave the weak excuse that in 12 years his lawyer always forbid him because of "windows".

Don't forget the fake Citi buy rating. Illegal and no one has bothered to investigate who ordered it. Lets hope SEC and DOJ have added this to their list of items to investigate.

You were probably asking "yes, Enron admitted there is an investigation going on, but WHERE is the proof that Jeffrey Skilling and Ken Lay are the ones being investigated?". It's called common sense. Here is a clue, if Cytodyn weren't being investigated by the SEC, they could have had an effective S-3 by now.

lol besides the numerous SEC filings and Tanya Urbach herself admitting the investigation going on. Why don't you ask Cytodyn why the SEC wont declare any S3 effective? 0.34, LMAO. When is Pourhassan getting more shares to finish his buyout? I assume via wire transfer to his broker in Iran?

You have no proof that the drug "works". All you have is Nader Pourhassan's word from years ago that they have a successful phase 3, the raw data of which was never released. The FDA made Cytodyn scrub all of Pourhassan's words from the website. Plus, you have a 20 page RTF letter from the FDA and the company itself is arguing the CRO did shoddy work. The FDA wrote a letter to Tony Migs telling him to stop saying the drug was safe and effective.

My bad for not specifying. in this case i meant the guy who was responsible for nearly 3 years of "material weakness" on the financial statements and also hyped up a nasdaq listing and dumped most of his shares into it. You're right though, Spokane Mike should also be sent with those guys.

Let's hope Naddir, Scotty, and Mikey get sent to the same place Mark Ahn did.

New 8K out. Is the 2x felon still being paid his buyout? Also, the company never explained why he was not fired for cause. Tanya Urbach and Scott Kelly need to address this, why the felon whose actions mainly put the company in its very precarious financial position got his golden parachute and wasn't fired for cause.

From today's 8K:

"The Company issued to a former executive officer a total of 23,651 shares of Common Stock to satisfy its obligation to make a severance payment of $8,042 for the payroll period ended May 15, 2022, net of payroll deductions and withholding taxes."

Someone on twitter once mentioned he does Airbnb as a side hustle so maybe he uses the LLC for Airbnb in addition to stock promotion?

Where are the partnerships after the big ASCO poster "presentation"? Is Scott Kelly still making $275K per month?

Market completely ignored mTNBC hodge podge of data from ASCO poster. Pumps aren't working. NASH 700mg results still being hidden from investors even though they've had them since Christmas 2021 when Reckner promised them. 0.34 LMAO!

Yep, also looks like the market was not impressed by the mTNBC data presented at ASCO. The facts remain that zero revenue is coming in and millions are owed to Samsung and Amarex with no way to pay them. Of course, the SEC and DOJ investigations are still looming and there is a disclaimer at the top of every page on cytodyn's website:

On February 11, 2022, CytoDyn, Inc. received a Warning Letter from the U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion in which FDA asserted that statements made in a video created a misleading impression regarding the safety and efficacy of leronlimab. Leronlimab is an investigational drug that has not been approved (or authorized) by the U.S. FDA for the treatment of COVID-19 or for any indication. For more information, click here to access a Dear Healthcare Provider (DHCP) Letter: View Here.

Its called common sense. Do you still need proof that the SEC and the DOJ are investigating Cytodyn? BuT tHey Are InVesTigatIng CiTron and AdAm. LMAO